In addition, the expression levels of Nanog, SOX2, Klf4 and Oct4 mRNA were also significantly decreased in the napabucasin-treated HCC cells in a concentration-dependent manner (Figure 4B). The gene discussed is POU5F1; the disease is hepatocellular carcinoma.